Eos Energy Enterprises enters September in a genuinely extreme position — the stock has collapsed 14% in a week, short sellers hold nearly 40% of the float, and the borrow market has effectively run dry.
The lending picture is about as tight as it gets. Availability has dropped to just 0.39% — meaning for every 255 shares already lent out to short sellers, barely one remains available to borrow. That is not a rounding error; it reflects a borrow market that has been at full capacity every single session since August 24. Prior to that, availability ran between 9% and 12% through most of August, making the sudden depletion over the final week of the month a notable structural shift. SI % of FF now stands at 39.4%, up roughly 7 percentage points from a month ago, even as it dipped slightly on the week. The ORTEX short score is running at 73.4, near the top of its recent range, with the factor score rank for short pressure in the bottom 2nd percentile of the universe — placing EOSE firmly among the most shorted names in the market. Cost to borrow has ticked up roughly 20% week-on-week to around 2%, though in absolute terms that remains modest. The paradox here is pointed: borrow availability is essentially exhausted, yet the cost of remaining shares is not yet punishing enough to force short-covering.
Options traders, meanwhile, are skewing bullish rather than cautious. The put/call ratio has dropped to 0.33, well below its 20-day mean of 0.36 and running near its lowest levels since late July. That is about 1.4 standard deviations below average — call buyers are outnumbering put buyers at an unusual rate even as the stock falls. The divergence between maximum short positioning in the equity lending market and call-leaning options flow is the central tension in EOSE this week.
The analyst community has been in consistent retreat on price targets, with every firm cutting targets following the August 5 earnings print that sent the stock down nearly 10% in a session. B. Riley lowered its target to $5 from $8 on August 14, keeping a Neutral rating. TD Cowen halved its target to $4, also Neutral. Stifel — still the lone Buy — trimmed to $9. The mean target across the coverage group has fallen to roughly $6.67 against a current price of $3.04, implying substantial implied upside on paper, but the direction of travel on targets has been uniformly downward. Bears point to near-term revenue compression from manufacturing consolidation and competition risk from rival battery chemistries. Bulls anchor on backlog growth, field performance data, and the energy storage market's structural tailwinds — with EPS surprise ranking in the 97th percentile, the company has historically beaten estimates even as the stock has continued to deteriorate.
The activist dimension adds an additional layer of complexity. Cerberus Capital Management holds a 32.6% stake via a Schedule 13D, having filed an amendment on August 6 that disclosed a rise from 31.1%. That is a controlling-scale position from a firm with an activist designation, and it has grown seven times since the initial filing in January 2025. Cerberus's continued accumulation at these levels is the most structurally meaningful ownership fact about this stock — though as with all 13D/G disclosures, the stake is as-last-reported and changes below the 5% threshold may not trigger further filings. BlackRock added over 3 million shares through July, taking its position to 7.4%. Hudson Bay Capital entered with a new 3.76% stake in Q2.
Earnings are not due until November 3, giving the market two full months to reassess. With availability essentially at zero and short interest near its highest level in months, the next move in either borrowing costs or available supply will be closely watched.
See the live data behind this article on ORTEX.
Open EOSE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
